ARCALIS, Inc. is a Japanese Contract Development and Manufacturing Organisation (CDMO) specialising in mRNA technology. The company provides a comprehensive range of fully integrated development services and cGMP-compliant mRNA and lipid nanoparticle (LNP) manufacturing services aimed at supporting clients in the pharmaceutical industry.

Services include:
– mRNA product development
– LNP formulation and production
– Analytical testing services
– Quality control and assurance
– Regulatory support
– Clinical supply manufacturing

As a leader in the field, ARCALIS, Inc. is committed to delivering high-quality, innovative solutions to its partners in the biotechnology and pharmaceutical sectors. For more information, please visit arcalis.co.jp.